Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Asep Medical Holdings Inc C.ASEP

Alternate Symbol(s):  SEPSF

ASEP Medical Holdings Inc. is a Canada-based company, which is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. The Company’s consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. It provides medical devices with an anti-microbial, antifouling coating through its SafeCoat Medical Inc. The Company provides diagnostic kits for predicting the onset of severe Sepsis and organ failure through its Sepset Biosciences Inc. The Company also offers peptide technology through its ABT Innovations Inc. and covers a range of therapeutic applications, including bacterial biofilm infections, anti-inflammatories, anti-infective immune-modulators and vaccine adjuvants. SafeCoat Medical Inc.'s technology incorporates self-assembling biocompatible polymers combined with conjugated antimicrobial peptides.


CSE:ASEP - Post by User

Post by culturedpiggy01on Jan 19, 2022 6:11pm
107 Views
Post# 34335125

$ASEP ‘s novel diagnostic assay for detecting sepsis faster

$ASEP ‘s novel diagnostic assay for detecting sepsis faster
was reading up on $ASEP.c and found this very interesting diagnostic assay they have developed to diagnose sepsis early. the detection is. based on unique molecular signatures in sepsis specific to the immune response, rather than the presence of a pathogen. You can learn more about it here: https://asepmedical.com/technologies/diagnostic/
 
There is some incredible research and data behind this and i think this could really change how we interact with antibiotics forever, highly recommend reading 
 
td, $ASEP.c trading at $0.60 with market cap at $33.68 M
<< Previous
Bullboard Posts
Next >>